{
    "info": {
        "nct_id": "NCT06340347",
        "official_title": "A PHASE 1, OPEN-LABEL, SINGLE-DOSE, NON-RANDOMIZED PARALLEL GROUP STUDY TO COMPARE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF OSIVELOTOR (PF-07940367) IN ADULT PARTICIPANTS WITH MILD AND MODERATE HEPATIC IMPAIRMENT",
        "inclusion_criteria": "* Body mass index (BMI) of 16 to 40 kg/m2, inclusive; and a total body weight greater than 50 kg (greater than 110 lb)\n* Stable hepatic impairment that meets the criteria for Class A or B of the Child Pugh classification with no clinically significant change in disease status within the 28 days prior to the screening visit\n* Stable concomitant medications for the management of individual participants' medical history\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Any condition possibly affecting drug absorption (eg, prior bariatric surgery, gastrectomy, ileal resection, prior status portacaval shunt surgery);\n* Hepatic carcinoma or hepatorenal syndrome or limited predicted life expectancy;\n* A diagnosis of hepatic dysfunction secondary to any acute ongoing hepatocellular process that is documented by medical history, physical examination, liver biopsy, hepatic ultrasound, computerized tomography scan, or MRI;\n* Presence of clinically active Stage 3 or 4 hepatic encephalopathy. Clinically active Stage 2 encephalopathy is allowed if, in the opinion of the investigator, the participant is able to provide informed consent.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stable concomitant medications for the management of individual participants' medical history",
            "criterions": [
                {
                    "exact_snippets": "Stable concomitant medications",
                    "criterion": "concomitant medications",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "management of individual participants' medical history",
                    "criterion": "medical history",
                    "requirements": [
                        {
                            "requirement_type": "management",
                            "expected_value": "with stable concomitant medications"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stable hepatic impairment that meets the criteria for Class A or B of the Child Pugh classification with no clinically significant change in disease status within the 28 days prior to the screening visit",
            "criterions": [
                {
                    "exact_snippets": "Stable hepatic impairment",
                    "criterion": "hepatic impairment",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "meets the criteria for Class A or B of the Child Pugh classification",
                    "criterion": "Child Pugh classification",
                    "requirements": [
                        {
                            "requirement_type": "class",
                            "expected_value": [
                                "A",
                                "B"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "no clinically significant change in disease status within the 28 days prior to the screening visit",
                    "criterion": "disease status change",
                    "requirements": [
                        {
                            "requirement_type": "clinically significant change",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Body mass index (BMI) of 16 to 40 kg/m2, inclusive; and a total body weight greater than 50 kg (greater than 110 lb)",
            "criterions": [
                {
                    "exact_snippets": "Body mass index (BMI) of 16 to 40 kg/m2, inclusive",
                    "criterion": "body mass index (BMI)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 16,
                                        "unit": "kg/m2"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 40,
                                        "unit": "kg/m2"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "total body weight greater than 50 kg (greater than 110 lb)",
                    "criterion": "total body weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 50,
                                "unit": "kg"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Presence of clinically active Stage 3 or 4 hepatic encephalopathy. Clinically active Stage 2 encephalopathy is allowed if, in the opinion of the investigator, the participant is able to provide informed consent.",
            "criterions": [
                {
                    "exact_snippets": "Presence of clinically active Stage 3 or 4 hepatic encephalopathy",
                    "criterion": "hepatic encephalopathy",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "Stage 3",
                                "Stage 4"
                            ]
                        },
                        {
                            "requirement_type": "clinical activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Clinically active Stage 2 encephalopathy is allowed if, in the opinion of the investigator, the participant is able to provide informed consent",
                    "criterion": "hepatic encephalopathy",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "Stage 2"
                        },
                        {
                            "requirement_type": "clinical activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability to provide informed consent",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hepatic carcinoma or hepatorenal syndrome or limited predicted life expectancy;",
            "criterions": [
                {
                    "exact_snippets": "Hepatic carcinoma",
                    "criterion": "hepatic carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatorenal syndrome",
                    "criterion": "hepatorenal syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "limited predicted life expectancy",
                    "criterion": "predicted life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": "limited"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition possibly affecting drug absorption (eg, prior bariatric surgery, gastrectomy, ileal resection, prior status portacaval shunt surgery);",
            "criterions": [
                {
                    "exact_snippets": "Any condition possibly affecting drug absorption",
                    "criterion": "condition affecting drug absorption",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior bariatric surgery",
                    "criterion": "prior bariatric surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "gastrectomy",
                    "criterion": "gastrectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "ileal resection",
                    "criterion": "ileal resection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior status portacaval shunt surgery",
                    "criterion": "prior portacaval shunt surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A diagnosis of hepatic dysfunction secondary to any acute ongoing hepatocellular process that is documented by medical history, physical examination, liver biopsy, hepatic ultrasound, computerized tomography scan, or MRI;",
            "criterions": [
                {
                    "exact_snippets": "A diagnosis of hepatic dysfunction secondary to any acute ongoing hepatocellular process",
                    "criterion": "hepatic dysfunction secondary to acute ongoing hepatocellular process",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented by medical history, physical examination, liver biopsy, hepatic ultrasound, computerized tomography scan, or MRI",
                    "criterion": "documentation of hepatic dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "documentation_method",
                            "expected_value": [
                                "medical history",
                                "physical examination",
                                "liver biopsy",
                                "hepatic ultrasound",
                                "computerized tomography scan",
                                "MRI"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}